Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -555.84%-4.84M | -171.58%-4.54M | 412.73%5.39M | -201.84%-2.16M | -233.41%-8.84M | 257.10%1.06M | 131.70%6.34M | -1.72M | 2.12M | 6.62M |
| Net profit before non-cash adjustment | 79.87%2.51M | 84.60%6.86M | 20,426.36%3.16M | -38.91%1.47M | -19.55%831K | 384.72%1.4M | 108.45%3.72M | ---15.56K | --2.41M | --1.03M |
| Total adjustment of non-cash items | -94.96%6K | -62.20%375.42K | -95.51%23.42K | -9.55%199K | -74.63%34K | 0.85%119K | -97.56%993.19K | --521.19K | --220K | --134K |
| -Depreciation and amortization | 23.33%148K | 8.02%537.1K | 0.62%144.1K | 52.17%175K | -15.52%98K | -2.44%120K | -72.55%497.22K | --143.22K | --115K | --116K |
| -Reversal of impairment losses recognized in profit and loss | ---- | -159.68%-44.78K | ---- | ---- | ---- | ---- | -98.85%75.03K | ---- | ---- | ---- |
| -Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Disposal profit | ---144K | -123.52%-95.94K | -116.20%-47.94K | -84.62%16K | -500.00%-64K | --0 | 47.26%407.9K | --295.9K | --104K | --16K |
| -Net exchange gains and losses | ---- | --0 | --0 | --0 | ---- | ---- | --0 | --1K | ---2K | ---- |
| -Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Other non-cash items | 300.00%2K | -260.57%-20.97K | -561.71%-27.97K | 166.67%8K | --0 | -133.33%-1K | -99.85%13.06K | --6.06K | --3K | --1K |
| Changes in working capital | -1,524.28%-7.36M | -821.59%-11.78M | 198.99%2.21M | -650.49%-3.84M | -277.80%-9.7M | 58.13%-453K | 109.77%1.63M | ---2.23M | ---511K | --5.46M |
| -Change in receivables | -172.04%-4.65M | 29.96%-13.55M | -451.94%-10.65M | -67.52%-7.62M | 72.35%-1.74M | 198.03%6.46M | -337.28%-19.34M | ---1.93M | ---4.55M | ---6.28M |
| -Change in inventory | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Change in payables | 1,799.62%8.97M | 92.67%-416.18K | 365.54%4.04M | -75.72%253K | -185.91%-4.18M | 85.87%-528K | -32,036.74%-5.68M | ---1.52M | --1.04M | ---1.46M |
| -Changes in other current assets | -83.10%-11.68M | -91.82%2.18M | 622.87%8.81M | 17.90%3.53M | -128.68%-3.79M | -169.06%-6.38M | 203.99%26.65M | --1.22M | --3M | --13.2M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | -2K | 30.07%-10.32K | -31.99%-2.32K | -100.00%-8K | 0 | 0 | 88.02%-14.76K | -1.76K | -4K | -3K |
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | 87.16%-100K | -71.82%-1.86M | 13.29%-516.34K | 5.95%-395K | -343.59%-173K | -2,496.67%-779K | -119.70%-1.08M | -595.46K | -420K | -39K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -1,846.64%-4.94M | -222.31%-6.42M | 309.95%4.87M | -251.00%-2.56M | -236.89%-9.01M | 139.75%283K | 125.43%5.25M | ---2.32M | --1.7M | --6.58M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | ---- | 97.75%-68.45K | -25.81%-8.45K | -1,100.00%-60K | --0 | --0 | -1,693.89%-3.04M | ---6.71K | --6K | ---6K |
| Net intangibles purchase and sale | -3.95%-79K | -43.05%-399.86K | ---108.86K | ---107K | ---108K | ---76K | ---279.53K | ---- | ---- | ---- |
| Net business purchase and sale | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net investment product transactions | ---- | --0 | --175K | --0 | ---- | ---- | 70.00%-300K | --0 | ---- | ---- |
| Interest received (cash flow from investment activities) | --0 | 2,118.79%31.29K | 759.80%30.29K | --0 | --0 | -66.67%1K | -97.13%1.41K | ---4.59K | --1K | --2K |
| Investing cash flow | -5.33%-79K | 87.91%-437.02K | 130.25%87.98K | 43.00%-167K | -6,975.00%-283K | 97.52%-75K | 41.31%-3.61M | ---290.84K | ---293K | ---4K |
| Financing cash flow | ||||||||||
| Net common stock issuance | ---- | --0 | --0 | --0 | --0 | --0 | -84.08%2.78M | --0 | --0 | --0 |
| Increase or decrease of lease financing | -7.41%-29K | 1.52%-112K | -47.01%-29K | 0.00%-28K | -7.69%-28K | 32.50%-27K | 93.81%-113.73K | ---19.73K | ---28K | ---26K |
| Net other fund-raising expenses | ---- | ---- | ---- | ---- | ---- | ---- | -229.00%-169.81K | ---243.81K | ---- | ---- |
| Financing cash flow | -7.41%-29K | -104.48%-112K | 89.00%-29K | -160.87%-28K | -7.69%-28K | -100.99%-27K | -83.96%2.5M | ---263.53K | --46K | ---26K |
| Net cash flow | ||||||||||
| Beginning cash position | -54.62%5.79M | 47.88%12.75M | -94.55%852K | -74.53%3.61M | 69.61%12.93M | 47.88%12.75M | -55.03%8.62M | --15.63M | --14.18M | --7.62M |
| Current changes in cash | -2,890.61%-5.05M | -268.71%-6.96M | 271.54%4.93M | -290.14%-2.76M | -242.27%-9.32M | 118.14%181K | 136.81%4.13M | ---2.88M | --1.45M | --6.55M |
| Effect of exchange rate changes | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| End cash Position | -94.32%735K | -54.62%5.79M | -54.62%5.79M | -94.55%852K | -74.53%3.61M | 69.61%12.93M | 47.88%12.75M | --12.75M | --15.63M | --14.18M |
| Free cash flow | -2,526.09%-5.02M | -456.86%-6.88M | 282.41%4.76M | -260.27%-2.73M | -238.66%-9.12M | 105.53%207K | 109.09%1.93M | ---2.61M | --1.7M | --6.58M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.